APA (7th ed.) Citation

Jin, J., Cui, G., Mi, N., Wu, W., Zhang, X., Xiao, C., . . . Li, J. (2023). Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects. European journal of pharmaceutical sciences, 185, 106448. https://doi.org/10.1016/j.ejps.2023.106448

Chicago Style (17th ed.) Citation

Jin, Jiangli, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of TG103, a Novel Long-acting GLP-1/Fc Fusion Protein After a Single Ascending Dose in Chinese Healthy Subjects." European Journal of Pharmaceutical Sciences 185 (2023): 106448. https://doi.org/10.1016/j.ejps.2023.106448.

MLA (9th ed.) Citation

Jin, Jiangli, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of TG103, a Novel Long-acting GLP-1/Fc Fusion Protein After a Single Ascending Dose in Chinese Healthy Subjects." European Journal of Pharmaceutical Sciences, vol. 185, 2023, p. 106448, https://doi.org/10.1016/j.ejps.2023.106448.